Related Experiment Video
Updated: Jun 17, 2025

13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
Controversies in prostate cancer screening
Daisy Obiora1, Oluwaseun Orikogbo1, Benjamin J Davies1
1Division of Health Services Research, Department of Urology, University of Pittsburgh Medical Center.
Urologic Oncology
|August 10, 2024
Abstract:
Prostate cancer is the second most diagnosed cancer and the fifth leading cause of cancer death among men worldwide. In the 1980s, the development and implementation of Prostate-Specific Antigen (PSA) testing for diagnosing prostate cancer led to a surge in the number of prostate cancer diagnoses. We explore the trends in recommendations and new innovations in adjunctive testing for prostate cancer screening.

